GLP-1 Coverage Guide is a private website. We are not Medicare, the Centers for Medicare & Medicaid Services (CMS), or any government agency, and we are not affiliated with or endorsed by them.
Text size:

Zepbound's dosing schedule, month by month

Published by GLP-1 Coverage Guide · Updated · No clinician review is credited for this page.

Short answer: The label starts Zepbound at 2.5 mg weekly for four weeks, with later 2.5 mg increases after at least four weeks at a dose. Labeled weight-management maintenance doses are 5, 10 or 15 mg weekly. Your prescriber selects the dose based on response and tolerability.

Sources for the coverage rules are listed below. An update date marks a revision; it does not imply a sitewide medical review.

Follow the prescription, not a fixed calendar

The maximum labeled dose is 15 mg weekly. Do not treat an intermediate escalation strength as a recommended maintenance dose without checking the indication and prescriber’s instructions. Ask the clinician about missed doses or interrupted treatment; this guide does not supply restart instructions.

Check coverage at each fill

Bridge coverage requires KwikPen. Confirm the prescribed strength, formulation, supply and authorization with the pharmacy. CMS says later fills do not require new PA unless changing to a different covered GLP-1 drug.

Take the Medicare eligibility check →

Common questions

Does the $50 copay guarantee treatment is appropriate?

No. Eligibility, authorization, pharmacy supply and clinical suitability are separate checks.

Can I change the dose or formulation myself?

Discuss changes with your prescriber and pharmacist. Follow the prescribed instructions and current form-specific labeling.

Related

Sources: CMS covered formulations and process · CMS prior authorization form · Zepbound prescribing information